title: [Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report].
abstract: In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the third annual series of workshops which brought together practitioners from all member centers and took place in October 2012 in Lille. Here the SFGM-TC addressed the issue of post-transplant CMV and EBV reactivation, and EBV-related Lymphoproliferative Disorders.
authors.affiliation: Service de thérapie cellulaire et hématologie clinique, CHU Estaing, 1, place Lucie et Raymond Aubrac, 63003 Clermont-Ferrand cedex 1, France.
authors.forename: J-O
authors.initials: JO
authors.lastname: Bay
authors.forename: R
authors.initials: R
authors.lastname: Peffault de Latour
authors.forename: B
authors.initials: B
authors.lastname: Bruno
authors.forename: V
authors.initials: V
authors.lastname: Coiteux
authors.forename: T
authors.initials: T
authors.lastname: Guillaume
authors.forename: Y
authors.initials: Y
authors.lastname: Hicheri
authors.forename: C
authors.initials: C
authors.lastname: Paillard
authors.forename: F
authors.initials: F
authors.lastname: Suarez
authors.forename: P
authors.initials: P
authors.lastname: Turlure
authors.forename: S
authors.initials: S
authors.lastname: Alain
authors.forename: C-E
authors.initials: CE
authors.lastname: Bulabois
authors.forename: G
authors.initials: G
authors.lastname: Socié
authors.forename: F
authors.initials: F
authors.lastname: Bauters
authors.forename: I
authors.initials: I
authors.lastname: Yakoub-Agha
mesh_terms: D003587:Cytomegalovirus / Q000502:physiology; D003586:Cytomegalovirus Infections / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D046148:Donor Selection / Q000592:standards; D020031:Epstein-Barr Virus Infections / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000592:standards; D004854:Herpesvirus 4, Human / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000592:standards / Q000706:statistics & numerical data; D008232:Lymphoproliferative Disorders / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D008991:Monitoring, Physiologic / Q000592:standards; D011322:Primary Prevention / Q000592:standards; D014184:Transplantation, Homologous; D014775:Virus Activation
keywords: Allogeneic stem cell transplantation; Allogreffe de cellules souches hématopoïétiques; CMV; EBV